Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma

PURPOSE: To assess the feasibility and safety of percutaneous intraductal radiofrequency ablation (RFA) for unresectable Bismuth types III and IV hilar cholangiocarcinoma. RESULTS: Percutaneous intraductal RFA combined with metal stent placement was successful in all patients without any technical p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Wang, Yu, Cui, Wei, Fan, Wenzhe, Zhang, Yingqiang, Yao, Wang, Huang, Kunbo, Li, Jiaping
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Clinical Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288231/
https://ncbi.nlm.nih.gov/pubmed/27322076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10116
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires